Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'trials phase'
trials phase published presentations and documents on DocSlides.
Vision for Clinical Trials and Clinical Trials Units in the Future
by belinda
Professor Julia . Brown. Leeds Institute of Clinic...
Demystifying Clinical Trials: Focusing on Trials with Therapeutic Intent
by tabitha
Ashley E. Ross MD PhD. Executive Medical Director....
Designing Phase I Trials With Targeted Agents:
by giovanna-bartolotta
Challenging Tradition. Chia-Chi (Josh) Lin, MD, P...
Clinical Trials in DMD
by margaret
Marina Di Marco. Principal Neuromuscular Physiothe...
Airspace Change Process & Airspace Trials in the contex
by myesha-ticknor
Modernising. UK Airspace. Darren Rhodes. Civil A...
Therapeutic Agents in Phase III Clinical Trials for Alzheimer’s (Registration Trials)
by sherrill-nordquist
As of 10/2018. Aducanumab: amyloid antibody. Biog...
SMALL SAMPLE SIZE CLINICAL TRIALS
by yvonne
Christopher S. Coffey. Professor, Department of Bi...
Trials Update May 2019 EuroEwings
by CuriousCatfish
2012. EE 2012. Now closed, . R1. recruited over i...
Global reach for Australian trials
by sadie
Anna Nowak. MBBS FRACP PhD. Chair, . CoOperative. ...
The Basics about Clinical Trials
by okelly
Covered in this presentation. Basic information ab...
Phase I trials: A New era in
by mitsue-stanley
OnCology. drug development. Jan 22, 2015. Method...
Biomarkers in Phase II designs in cancer clinical trials
by conchita-marotz
Methods in Clinical Cancer Research. February 12,...
Trial Design Issues for Phase II Trials
by audrey
Guide to Two-Stage . IIa. Designs and . IIa. /IIb...
What's New in Atopic Dermatitis
by cheryl-pisano
Changing Landscape of Therapeutic Options. Burden...
in Paediatric Palliative Medicine
by ariel
Research. Outline. Is research for me?. Share some...
Design considerations for drug development in the era of immuno-oncology
by isabella
Elizabeth Garrett-Mayer, PhD. Director, Division o...
My Experiences as an FDA Statistician
by aaron
Yeh-Fong Chen, Ph.D. . FDA/CDER/OB/DB3. CBA 2016-...
The Westmead and MIA
by myesha-ticknor
Phase I experience. Matteo Carlino. Crown Princes...
Clinical Trial Protocol & Amendments
by liane-varnes
William Petros, PharmD, FCCP. Professor, Schools ...
New Prevention Technologies Workshop
by sherrill-nordquist
Module 3: Overview of Prevention Research. www.ic...
Drug development
by lindy-dunigan
. Recognise the use of plants as sources of medi...
The Basics about Clinical Trials Covered in this
by yoshiko-marsland
The Basics about Clinical Trials Covered in this p...
What is it like to participate in a clinical trial?
by samir599
Karen-Sue Carlson, MD, PhD. Associate Professor of...
July 2015 PRABHAVATHI FERNANDES, PhD
by fauna
Founder, President and CEO. How the PATH Act Can R...
The (frequently long, circuitous, and
by jaena
bumpy) trip from clinical problems to clinical tri...
2020 Trends In Biostatistics
by harper
What you should know about study design. Demonstra...
1 Lecture3 Experiment, trial and survey
by freya
Collecting data. 2. Data . Statistics is a way of ...
735V 17 2009practitioners There is a mention of demerits of theconju
by josephine
Consultant Pediatrcian,Pedicare, Ratu Road,rch_sss...
Researched and
by gagnon
Authored by Prof Michael C Herbst [D Litt et Phil ...
Johanna Mielke, Bernd Jilma
by LittleMissPerfect
, . Franz Koenig, Byron . Jones. Clinical trials f...
Part in Cancer Treatment Research StudiesUS Department of Health Huma
by cora
Taking 1-800-4-CANCER 1-800-422-6237Taking Part in...
Molecular Lessons Learnt from Clinical Trials in the Last Decade
by altigan
Andrew X. Zhu, MD, PhD. Harvard Medical School. Ma...
Snapshot of the Clinical Trials
by dsuser1
Enterprise as . revealed by . ClinicalTrials.gov. ...
Positive Impacts of Developing Novel Endpoints
by ryotheasy
Generated by Mobile Technology for . Use in Clinic...
Clinical Trials: What you need to know to study diet and nutritional variables
by startse
(emphasis on fruits and vegetables and their compo...
Safety Considerations in Phase 1 Trials
by stefany-barnette
Sumathi Nambiar MD MPH. Director. Division of Ant...
“ 28,424 cases of Ebola and still counting—what have we learned?”
by mitsue-stanley
AAMC Briefing. Dr. Jim LeDuc. Director. Galveston...
Regulatory issues in HIV cure Research
by debby-jeon
HIV Cure Research Training Curriculum. Regulatory...
Drug Development : Basic
by myesha-ticknor
Overview of Clinical Trials. : Phase I-III. Patr...
Should I Enroll in a Clinical Trial?
by tatyana-admore
David N. Assis, MD. Assistant Professor of Medici...
Load More...